Skip to main content
. 2016 Jun 8;3(2):123–132. doi: 10.1093/ehjqcco/qcw030

Table 1.

Contextual details of included studies

Author, year Country Definition of frailty n Mean age (years) Male gender (%) Proportion frail (%) TAVI access route 30-day mortality (%) 1-year mortality (%)
Ewe, 201020 The Netherlands/Italy Fried criteria based on gait speed, grip strength, weight loss, physical activity, and exhaustion 147 80 43 32.7 Femoral 51%, apical 49% 6.8 15.0
Stortecky, 201235 Switzerland Frailty index based on geriatric assessment of cognition, nutrition, timed get-up-and-go, ADLs, and disability. Scored 0–7 with ≥3 considered frail 100 84 40 49 Femoral 85%, apical 14%, subclavian 1% 8.0 19.0
Rodés-Cabau, 201236 Canada Subjective assessment of multidisciplinary team 339 81 45 25.1 Femoral 48%, apical 52% 10.6
Kamga, 201319 Belgium ISAR score (self-reported functional dependence, recent hospitalization, impaired memory, difficulties with vision and polypharmacy)
SHERPA score (age, ADLs, cognitive decline, falls, and self-perceived health)
30 86 53 ISAR: 83.3% moderate or high risk
SHERPA: 73.3% moderate or high risk
Femoral 100% 26.7
Zahn, 201337 Germany Presumed subjective assessment (limited detail) 1318 82 42 17.7 Femoral 88%, apical 9%, subclavian 2%, aortic 1% 19.9
Puls, 201438 Germany Katz index of ADLs (score <6 frail) 300 82 34 48 Femoral 47%, apical 53% 11.3 28
Seiffert, 201439 Germany Subjective assessment guided by CHSA clinical frailty scale29 score ≥6 347a 81 52 4.6 24.2
Capodanno, 201440 Italy Geriatric status scale based on ADLs, cognition, continence, and mobility. Scored 0–3 with ≥2 labelled frail 1256b 82 42 24.4 6.1
Debonnaire, 201541 The Netherlands/Italy Presumed subjective assessment 511 82 38 19.2 Femoral 52%, apical 48% 5.7 15.7
Green, 201542 USA Frailty score composed of serum albumin, grip strength, gait speed, and ADLs. Scored between 0 and 12 with ≥6 considered frail 244 86 52 45.1 Femoral 49%, others presumed apical 8.6 23.5

ADLs, activities of daily living.

Observed mortality data refer to the whole study population including frail and non-frail individuals.

aOnly the Bonn subgroup that received frailty assessment considered from this multicentre study.

bOnly the development cohort of this study included. The validation data set does not contain frailty related outcome data.